| 发明名称 | Use of simalikalactone E as an anticancer agent | ||
| 摘要 | The invention relates to Simalikalactone E (SkE) to be used for preventing and/or treating cancers. | ||
| 申请公布号 | US8987324(B2) | 申请公布日期 | 2015.03.24 |
| 申请号 | US201213979647 | 申请日期 | 2012.01.13 |
| 申请人 | Institut de Recherche pour le Developpement | 发明人 | Bourdy Geneviève;Auberger Patrick;Jullian Valérie;Robert Guillaume;Deharo Eric |
| 分类号 | A61K31/366;A61K45/06 | 主分类号 | A61K31/366 |
| 代理机构 | Morgan, Lewis & Bockius LLP | 代理人 | Morgan, Lewis & Bockius LLP |
| 主权项 | 1. A method of treating cancer in which Ras/Raf/MEK/Erk signaling pathway is activated in a patient comprising a step of administering Simalikalactone E corresponding to formula 1 below: to the patient in an amount effective to treat said cancer, wherein the Ras/Raf/MEK/Erk signaling pathway is activated in the cancer. | ||
| 地址 | Marseilles FR | ||